Application of Mesenchymal Stem Cells for the Treatment of Liver Graft Dysfunction Caused by Chronic Rejection. Case Report

被引：0
|
作者：
Korotkov, Sergey [1 ]
Lebed, Olga [1 ]
Smolnikova, Victoriya [1 ]
Shcherba, Aleksey [1 ]
Krivenko, Svetlana [1 ]
Rummo, Oleg [1 ]
机构：
[1] Minsk Sci & Pract Ctr Surg Transplantol & Hematol, Transplant Dept, Minsk, BELARUS
来源：
TRANSPLANTATION | 2022年 / 106卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P9.34
引用
收藏
页码：S651 / S651
页数：1
相关论文
共 50 条
  • [1] The significance of parenchymal changes of acute rejection in predicting chronic liver graft rejection.
    Gouw, ASH
    van den Heuvel, MC
    van den Berg, AP
    Slooff, MJH
    de Jong, KP
    Poppema, S
    TRANSPLANTATION, 2000, 69 (08) : S120 - S120
  • [2] Absence of putative hepatic stem cells in end-stage chronic liver allograft rejection.
    van den Heuvel, MC
    de Jong, KP
    van der Horst, MLC
    van den Berg, AP
    Poppema, S
    Slooff, MJH
    Gouw, ASH
    HEPATOLOGY, 2000, 32 (04) : 479A - 479A
  • [3] Autologous Mesenchymal Stem Cells for Treatment of Chronic Antibody-Mediated Kidney Graft Rejection: Report of the First Phase I/II Clinical Case Series.
    Veceric-Haler, Z.
    Sever, M.
    Kojc, N.
    Mlinsek, G.
    Oblak, M.
    Halloran, P.
    Rigler, A. Ales
    Ponikvar, J. Buturovic
    Arnol, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 411 - 412
  • [4] Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series
    Veceric-Haler, Zeljka
    Sever, Matjaz
    Kojc, Nika
    Halloran, Philip F.
    Bostjancic, Emanuela
    Mlinsek, Gregor
    Oblak, Manca
    Pozenel, Primoz
    Svajger, Urban
    Hartman, Katrina
    Knezevic, Miomir
    Barlic, Ariana
    Girandon, Lenart
    Rigler, Andreja Ales
    Zver, Samo
    Ponikvar, Jadranka Buturovic
    Arnol, Miha
    TRANSPLANT INTERNATIONAL, 2022, 35
  • [5] Effect of Adipose Tissue-Derived Mesenchymal Stem Cells in a Rat Model of Chronic Renal Allograft Rejection.
    Pepineli, R.
    Silva, F.
    Gouveia, P.
    Tavora, G.
    Gomes, S.
    Noronha, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 371 - 371
  • [6] Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.
    Grimm, PC
    Nickerson, P
    Jeffery, J
    Savani, RC
    Gough, J
    McKenna, RM
    Stern, E
    Rush, DN
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (02): : 93 - 97
  • [7] Application of Modified Mesenchymal Stem Cells Transplantation in the Treatment of Liver Injury
    Liu, Liyuan
    Yang, Fuyuan
    PHYSIOLOGICAL RESEARCH, 2021, 70 (03) : 327 - 343
  • [8] Analysis of sirolimus in liver transplantation, the effect on chronic renal dysfunction, adverse events and allograft rejection.
    Gilroy, RK
    McCashland, TM
    Mukherjee, SE
    Lyden, E
    Grant, W
    Schafer, DF
    Sorrell, MF
    Mejia, A
    Sudan, D
    Langnas, A
    Shaw, BW
    HEPATOLOGY, 2002, 36 (04) : 185A - 185A
  • [9] Mesenchymal stem cells for treatment of refractory chronic graft-versus-host disease
    Weng Jianyu
    Xin Du
    Xiang Peng
    Zhang Xiumin
    Wu, Suijin
    Lu, Zesheng
    Luo, Chengwei
    Guo, Rong
    Deng, Chengxin
    Ling, Wei
    Lin, Wei
    Huang, Zilun
    BLOOD, 2007, 110 (11) : 319B - 319B
  • [10] TREATMENT OF BONE MARROW HYPOPLASIA WITH MESENCHYMAL STEM CELLS - CASE REPORT
    Amorim, V. M.
    Junior, C. A. C.
    Brunel, H. S. S.
    Malard, P. F.
    CYTOTHERAPY, 2021, 23 (04) : 36 - 36
12345